Construction and characterization of OV-Q1, OV-CD47-G1, and OV-CD47-G4. cells, mediate the anti-tumor cytotoxicity of antibody-producing oncolytic herpesviruses. Collectively, oncolytic herpes simplex computer virus-1 encoding full-length antibodies could improve immune-virotherapy for glioblastoma. Subject terms:Malignancy microenvironment, Immunotherapy, CNS cancer, Malignancy immunotherapy Oncolytic herpes simplex computer virus-1 TAS 103 2HCl lyses cancer cells while increases their immunogenicity. Blocking […]